mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
1e-06 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.28 |
1e-06 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.26 |
1e-06 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-06 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.29 |
3e-06 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
5e-06 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
6e-06 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |